| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,300,000 | 6,719,000 | 4,523,000 | 4,654,000 | | Cost of Revenue | 4,015,000 | 4,263,000 | 2,481,000 | 2,806,000 | | | Gross Profit | 2,285,000 | 2,456,000 | 2,042,000 | 1,848,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 751,000 | 738,000 | 717,000 | 693,000 | | Non Recurring | 133,000 | 38,000 | 128,000 | 155,000 | | Others | 7,000 | 3,000 | 6,000 | 2,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,394,000 | 1,677,000 | 1,191,000 | 998,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (344,000) | | Earnings Before Interest And Taxes | 1,513,000 | 1,894,000 | 1,297,000 | 1,121,000 | | Interest Expense | 279,000 | 287,000 | 336,000 | 140,000 | | Income Before Tax | 1,234,000 | 1,607,000 | 961,000 | 981,000 | | Income Tax Expense | 352,000 | 596,000 | 372,000 | 302,000 | | Minority Interest | (1,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 881,000 | 1,011,000 | 589,000 | 679,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 881,000 | 1,011,000 | 589,000 | 679,000 | | Preferred Stock And Other Adjustments | 1,000 | (1,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $882,000 | $1,010,000 | $589,000 | $679,000 |
|
0.28% Nasdaq 
Income Statement
